HeyJaredThe BioHub: The Top Voices in Biotech
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech.
- Indexed episodes, last 90 days
- 37
- Latest publication
- Sep 22, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Episode 231 - Stacy Blain - CEO & Founder of Concarlo Therapeutics (opens the original)
Read excerpt
Today we’re joined by Dr. Stacy Blain, Founder and CEO of Concarlo Therapeutics. Stacy has spent more than 30 years working in cell cycle and cancer biology, including two decades as a tenured professor and NIH-funded researcher at SUNY Downstate. She then made the transition from academia into entrepreneurship, founding Concarlo to develop new approaches to treating drug-resistant cancers. At Concarlo, Stacy and the team are focused on p27 biology and developing their LOCKTAC approach to target
Episode 230 - Nick Sireau - Chairman at Serenatis Bio (opens the original)
Read excerpt
In this episode of The BioHub Podcast by Avetix, Ben O’Keefe sits down with Nick Sireau, Executive Chairman and Co-Founder of Serenatis Bio, to discuss the company’s mission to develop a new generation of treatments for obsessive-compulsive disorder (OCD). Nick shares the deeply personal story behind Serenatis, from his own experience living with OCD to the loss of a close friend to the condition, and how that ultimately helped shape the company’s focus. They explore why OCD remains a significan
Episode 229 - Frederic Marrache - CEO of Bionyra (opens the original)
Read excerpt
On this episode we feature the CEO of Bionyra, Frederic Marrache, after closing French-biotech's largest ever Series A ($165million) this summer. Bionyra are a Sofinnova-incubated I&I biotech advancing in-licensed monoclonal (TL1A & IL25) & bispecific (TL1AxIL-23p19) HLE antibodies for a range of autoimmune indications. In this conversation we discuss why, after a decade within Sanofi's I&I development organisation, Frederic viewed the Bionyra opportunity as 'the one' to scratch his biotech itch
Episode 228 - Edward Van Wezel - Founder BGV (opens the original)
Read excerpt
In this episode of The BioHub by Avetix , I’m joined by Edward van Wezel , Managing Partner and Co-Founder of BioGeneration Ventures . Edward shares his journey into venture capital and the story behind building BGV into one of Europe’s leading early-stage life sciences investors. We discuss how he evaluates companies at the earliest stages, what he looks for in founders and leadership teams, and the lessons behind standout investments such as Acerta Pharma. We also explore the evolution of the
Episode 227 - Jo Lane - VP People at Compass Pathways (opens the original)
Read excerpt
Today, I’m joined by Jo Lane, a senior People and HR leader currently working with COMPASS Pathways, where she plays a key role in supporting the organisation and its people as the company continues to develop and grow. Jo has built an impressive career across the life sciences and healthcare sectors, with senior HR and organisational development roles at COMPASS Pathways, Ipsen and IQVIA. Her experience spans people strategy, organisational development, talent, leadership, change and building h
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.